| Year |
Citation |
Score |
| 2024 |
Soung YH, Chung H, Yan C, Fesler A, Kim H, Oh ES, Ju J, Chung J. Correction: Soung et al. Therapeutic Potential of Chemically Modified MiR-489 in Triple-Negative Breast Cancers. 2020, , 2209. Cancers. 16. PMID 38473436 DOI: 10.3390/cancers16051010 |
0.401 |
|
| 2023 |
Soung YH, Ju J, Chung J. The Sensitization of Triple-Negative Breast Cancers to Poly ADP Ribose Polymerase Inhibition Independent of BRCA1/2 Mutation Status by Chemically Modified microRNA-489. Cells. 13. PMID 38201253 DOI: 10.3390/cells13010049 |
0.521 |
|
| 2023 |
Pal A, Ojha A, Ju J. Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer. International Journal of Molecular Sciences. 24. PMID 38139352 DOI: 10.3390/ijms242417523 |
0.421 |
|
| 2023 |
Yuen JG, Hwang GR, Fesler A, Intriago E, Pal A, Ojha A, Ju J. Development of Gemcitabine-Modified miRNA Mimics as Cancer Therapeutics for Pancreatic Ductal Adenocarcinoma. Biorxiv : the Preprint Server For Biology. PMID 37645827 DOI: 10.1101/2023.08.14.553255 |
0.59 |
|
| 2023 |
Yuen JG, Hwang GR, Ju J. Analysis of MicroRNAs in Ferroptosis. Methods in Molecular Biology (Clifton, N.J.). 2712: 223-232. PMID 37578710 DOI: 10.1007/978-1-0716-3433-2_20 |
0.34 |
|
| 2023 |
Hwang GR, Yuen JG, Fesler A, Farley H, Haley JD, Ju J. Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer. Molecular Therapy Oncolytics. 28: 277-292. PMID 36911069 DOI: 10.1016/j.omto.2023.02.007 |
0.592 |
|
| 2023 |
Almanzar VMD, Shah K, LaComb JF, Mojumdar A, Patel HR, Cheung J, Tang M, Ju J, Bialkowska AB. 5-FU-miR-15a Inhibits Activation of Pancreatic Stellate Cells by Reducing YAP1 and BCL-2 Levels In Vitro. International Journal of Molecular Sciences. 24. PMID 36835366 DOI: 10.3390/ijms24043954 |
0.508 |
|
| 2023 |
Patel HR, Diaz Almanzar VM, LaComb JF, Ju J, Bialkowska AB. The Role of MicroRNAs in Pancreatitis Development and Progression. International Journal of Molecular Sciences. 24. PMID 36674571 DOI: 10.3390/ijms24021057 |
0.463 |
|
| 2022 |
Yuen JG, Fesler A, Hwang GR, Chen LB, Ju J. Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 35933584 DOI: 10.1016/j.ymthe.2022.07.015 |
0.416 |
|
| 2022 |
Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B, Zhao J, Xia S, Fan S, Yu X, Du Y, Hou L, Li Z, Ding Z, An S, ... ... Ju J, et al. Corrigendum to "Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer" [Canc. Lett. 459 (2019 Sep 10) 122-134]. Cancer Letters. 215695. PMID 35501203 DOI: 10.1016/j.canlet.2022.215695 |
0.487 |
|
| 2021 |
Zhou Q, Li Y, Chen L, Zheng X, Jiang T, Liu J, Fu Y, Guan L, Ju J, Wu C. Long Non-Coding RNA GRIK1-AS1 Inhibits the Proliferation and Invasion of Gastric Cancer Cells by Regulating the miR-375/IFIT2 Axis. Frontiers in Oncology. 11: 754834. PMID 34660323 DOI: 10.3389/fonc.2021.754834 |
0.534 |
|
| 2021 |
Hwang GR, Yuen JG, Ju J. Roles of microRNAs in Gastrointestinal Cancer Stem Cell Resistance and Therapeutic Development. International Journal of Molecular Sciences. 22. PMID 33562727 DOI: 10.3390/ijms22041624 |
0.426 |
|
| 2020 |
Liu J, Wu S, Zheng X, Zheng P, Fu Y, Wu C, Lu B, Ju J, Jiang J. Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions. Scientific Reports. 10: 14749. PMID 32901082 DOI: 10.1038/S41598-020-71573-Y |
0.369 |
|
| 2020 |
Soung YH, Chung H, Yan C, Fesler A, Kim H, Oh ES, Ju J, Chung J. Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers. Cancers. 12. PMID 32784600 DOI: 10.3390/Cancers12082209 |
0.647 |
|
| 2020 |
Fesler A, Hwang G, Yuen J, Ju J. Abstract 4063: Design and development of a novel 5-FU modified siRNA against BCL2 with enhanced efficacy and the unique ability to be delivered vehicle free into cancer cells Cancer Research. 80: 4063-4063. DOI: 10.1158/1538-7445.Am2020-4063 |
0.443 |
|
| 2019 |
Fesler A, Ju J. Development of microRNA-based therapy for pancreatic cancer. Journal of Pancreatology. 2: 147-151. PMID 32133215 DOI: 10.1097/jp9.0000000000000029 |
0.375 |
|
| 2019 |
Guo S, Fesler A, Huang W, Wang Y, Yang J, Wang X, Zheng Y, Hwang GR, Wang H, Ju J. Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma. Molecular Therapy. Nucleic Acids. 19: 228-239. PMID 31846800 DOI: 10.1016/J.Omtn.2019.11.010 |
0.594 |
|
| 2019 |
Su W, Xiao W, Chen L, Zhou Q, Zheng X, Ju J, Jiang J, Wang Z. Decreased IFIT2 Expression In Human Non-Small-Cell Lung Cancer Tissues Is Associated With Cancer Progression And Poor Survival Of The Patients. Oncotargets and Therapy. 12: 8139-8149. PMID 31632065 DOI: 10.2147/Ott.S220698 |
0.423 |
|
| 2019 |
Soung YH, Chung H, Yan C, Ju J, Chung J. Arrestin Domain Containing 3 Reverses Epithelial to Mesenchymal Transition and Chemo-Resistance of TNBC Cells by Up-Regulating Expression of miR-200b. Cells. 8. PMID 31295851 DOI: 10.3390/cells8070692 |
0.558 |
|
| 2019 |
Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B, Zhao J, Xia S, Fan S, Yu X, Du Y, Hou L, Li Z, Ding Z, An S, ... ... Ju J, et al. Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer. Cancer Letters. PMID 31173853 DOI: 10.1016/J.Canlet.2019.05.035 |
0.654 |
|
| 2019 |
Guo S, Fesler A, Huang W, Wang Y, Yang J, Wang X, Hwang G, Godwin M, Wang H, Ju J. Abstract 2592: Development of a novel modified miR-15a mimic with enhanced therapeutic potential for treatment of pancreatic ductal adenocarcinoma Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2592 |
0.52 |
|
| 2018 |
Xu YC, Liu X, Li M, Li Y, Li CY, Lu Y, Sanches J, Wang L, Du Y, Mao LM, Zuo SB, Liu HT, Shen J, Wang B, Hou L, ... ... Ju JF, et al. A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID. Molecular Therapy. Nucleic Acids. 12: 578-590. PMID 30195794 DOI: 10.1016/j.omtn.2018.06.011 |
0.58 |
|
| 2018 |
Guo S, Fesler A, Wang H, Ju J. microRNA based prognostic biomarkers in pancreatic Cancer. Biomarker Research. 6: 18. PMID 29942514 DOI: 10.1186/S40364-018-0131-1 |
0.453 |
|
| 2018 |
Wu N, Fesler A, Liu H, Ju J. Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells. Oncotarget. 9: 8887-8897. PMID 29507661 DOI: 10.18632/Oncotarget.22322 |
0.567 |
|
| 2018 |
Sanches J, Xu Y, Yabasin IB, Li M, Lu Y, Xiu X, Wang L, Mao L, Shen J, Wang B, Hou L, Ju J, Zhao J, Song B. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD. Chemico-Biological Interactions. PMID 29477382 DOI: 10.1016/j.cbi.2018.02.024 |
0.562 |
|
| 2018 |
Fesler A, Liu H, Ju J. Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1. Oncotarget. 9: 2367-2383. PMID 29416778 DOI: 10.18632/Oncotarget.23414 |
0.605 |
|
| 2018 |
Fesler A, Guo S, Ye Z, Godwin M, Wang H, Ju J. Abstract 4403: Development of 5-FU modified tumor suppressor miRNAs as a platform for miRNA based cancer therapeutics Cancer Research. 78: 4403-4403. DOI: 10.1158/1538-7445.Am2018-4403 |
0.596 |
|
| 2017 |
Yang J, Ma D, Fesler A, Zhai H, Leamniramit A, Li W, Wu S, Ju J. Expression analysis of microRNA as prognostic biomarkers in colorectal cancer. Oncotarget. 8: 52403-52412. PMID 28881738 DOI: 10.18632/Oncotarget.14175 |
0.626 |
|
| 2017 |
Fesler A, Liu H, Wu N, Liu F, Ling P, Ju J. Autophagy regulated by miRNAs in colorectal cancer progression and resistance. Cancer Translational Medicine. 3: 96-100. PMID 28748218 DOI: 10.4103/Ctm.Ctm_64_16 |
0.499 |
|
| 2017 |
Fesler A, Guo S, Liu H, Wu N, Ju J. Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancer. Epigenomics. PMID 28517961 DOI: 10.2217/Epi-2017-0041 |
0.453 |
|
| 2017 |
Fesler AT, Liu H, Wu N, Ju J. Abstract 5443: Developing a novel miR-15a mimic as a potential therapeutic molecule to eliminate resistant colorectal cancer stem cells Cancer Research. 77: 5443-5443. DOI: 10.1158/1538-7445.Am2017-5443 |
0.659 |
|
| 2017 |
Fesler AT, Wu N, Liu H, Ju J. Abstract 2141: Development of a novel miR-129 mimic with enhanced therapeutic potential for treatment of resistant colorectal cancer Cancer Research. 77: 2141-2141. DOI: 10.1158/1538-7445.Am2017-2141 |
0.692 |
|
| 2016 |
Yang J, Ma D, Fesler A, Zhai H, Leamniramit A, Li W, Wu S, Ju J. Expression analysis of microRNA as prognostic biomarkers in colorectal cancer. Oncotarget. PMID 28039449 DOI: 10.18632/oncotarget.14175 |
0.559 |
|
| 2016 |
Wu S, Fesler A, Ju J. Implications of Circadian Rhythm Regulation by microRNAs in Colorectal Cancer. Cancer Translational Medicine. 2: 1-6. PMID 27747302 DOI: 10.4103/2395-3977.177555 |
0.518 |
|
| 2016 |
Li J, Ju J, Ni B, Wang H. The emerging role of miR-506 in cancer. Oncotarget. PMID 27542202 DOI: 10.18632/Oncotarget.11294 |
0.687 |
|
| 2016 |
Fesler A, Zhang N, Ju J. The expanding regulatory universe of p53 in gastrointestinal cancer. F1000research. 5: 756. PMID 27508057 DOI: 10.12688/F1000Research.8363.1 |
0.477 |
|
| 2016 |
Li J, Wu H, Li W, Yin L, Guo S, Xu X, Ouyang Y, Zhao Z, Liu S, Tian Y, Tian Z, Ju J, Ni B, Wang H. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling. Oncogene. PMID 27065335 DOI: 10.1038/Onc.2016.90 |
0.694 |
|
| 2016 |
Wu C, Zheng X, Li X, Fesler A, Hu W, Chen L, Xu B, Wang Q, Tong A, Burke S, Ju J, Jiang J. Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation. Oncotarget. PMID 26894855 DOI: 10.18632/Oncotarget.7392 |
0.589 |
|
| 2016 |
Ouyang Y, Pan J, Tai Q, Ju J, Wang H. Transcriptomic changes associated with DKK4 overexpression in pancreatic cancer cells detected by RNA-Seq. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26880586 DOI: 10.1007/S13277-015-4379-X |
0.427 |
|
| 2016 |
Ma D, Xue Y, Fesler A, Zhai H, Yang J, Ieamniramit A, Li W, Ju J. Abstract 1968: Systematic validation of microRNA based prognostic biomarkers for stage II, III and IV colorectal cancer Cancer Research. 76: 1968-1968. DOI: 10.1158/1538-7445.Am2016-1968 |
0.524 |
|
| 2015 |
Fesler A, Xu X, Zheng X, Li X, Jiang J, Russo JJ, Ju J. Identification of miR-215 mediated targets/pathways via translational immunoprecipitation expression analysis (TrIP-chip). Oncotarget. 6: 24463-73. PMID 26287603 DOI: 10.18632/Oncotarget.4425 |
0.585 |
|
| 2015 |
Zhai H, Fesler A, Ba Y, Wu S, Ju J. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy. Oncotarget. 6: 19735-46. PMID 25980495 DOI: 10.18632/Oncotarget.3771 |
0.675 |
|
| 2015 |
Zhai H, Fesler A, Ju J. Abstract 3117: Hsa-miR-140-5p inhibits colorectal cancer stem cell invasion and metastasis by suppressing Smad2 and autophagy Cancer Research. 75: 3117-3117. DOI: 10.1158/1538-7445.Am2015-3117 |
0.668 |
|
| 2015 |
Fesler A, Zhai H, Ju J. Abstract 3079: Mechanism of hsa-miR-15a in EMT and chemoresistance in colorectal cancer Cancer Research. 75: 3079-3079. DOI: 10.1158/1538-7445.Am2015-3079 |
0.633 |
|
| 2014 |
Fesler A, Zhai H, Ju J. miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer. Oncotargets and Therapy. 7: 1481-5. PMID 25187728 DOI: 10.2147/Ott.S65548 |
0.544 |
|
| 2014 |
Liu J, Shi W, Wu C, Ju J, Jiang J. miR-181b as a key regulator of the oncogenic process and its clinical implications in cancer (Review). Biomedical Reports. 2: 7-11. PMID 24649060 DOI: 10.3892/Br.2013.199 |
0.654 |
|
| 2014 |
Fesler A, Jiang J, Zhai H, Ju J. Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients. Molecular Diagnosis & Therapy. 18: 303-8. PMID 24566942 DOI: 10.1007/S40291-014-0089-0 |
0.438 |
|
| 2014 |
Guo S, Xu X, Tang Y, Zhang C, Li J, Ouyang Y, Ju J, Bie P, Wang H. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. Cancer Letters. 344: 40-6. PMID 24252251 DOI: 10.1016/J.Canlet.2013.10.009 |
0.537 |
|
| 2014 |
Dong P, Kaneuchi M, Xiong Y, Cao L, Cai M, Liu X, Guo SW, Ju J, Jia N, Konno Y, Watari H, Hosaka M, Sudo S, Sakuragi N. Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer. Carcinogenesis. 35: 760-8. PMID 24220291 DOI: 10.1093/Carcin/Bgt369 |
0.43 |
|
| 2014 |
Fesler A, Xu X, Chen E, Ju J. Abstract 5247: Comprehensive and systematic identification of miR-215 targets in colon cancer via a novel translation capture immunoprecipitation (TrIP) approach Cancer Research. 74: 5247-5247. DOI: 10.1158/1538-7445.Am2014-5247 |
0.569 |
|
| 2013 |
Zhai H, Karaayvaz M, Dong P, Sakuragi N, Ju J. Prognostic significance of miR-194 in endometrial cancer. Biomarker Research. 1. PMID 24040515 DOI: 10.1186/2050-7771-1-12 |
0.789 |
|
| 2013 |
Zhai H, Fesler A, Schee K, Fodstad O, Flatmark K, Ju J. Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. Clinical Colorectal Cancer. 12: 261-6. PMID 24012455 DOI: 10.1016/J.Clcc.2013.06.003 |
0.393 |
|
| 2013 |
Karaayvaz M, Zhai H, Ju J. miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cell Death & Disease. 4: e659. PMID 23744359 DOI: 10.1038/Cddis.2013.193 |
0.79 |
|
| 2013 |
Ju J, Jiang J, Fesler A. miRNA: the new frontier in cancer medicine. Future Medicinal Chemistry. 5: 983-5. PMID 23734680 DOI: 10.4155/Fmc.13.74 |
0.451 |
|
| 2013 |
Wang M, Li C, Yu B, Su L, Li J, Ju J, Yu Y, Gu Q, Zhu Z, Liu B. Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. Journal of Gastroenterology. 48: 1023-33. PMID 23338485 DOI: 10.1007/s00535-012-0733-6 |
0.518 |
|
| 2013 |
Zhai H, Fesler A, Ju J. MicroRNA: a third dimension in autophagy. Cell Cycle (Georgetown, Tex.). 12: 246-50. PMID 23255136 DOI: 10.4161/Cc.23273 |
0.454 |
|
| 2013 |
Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, Sudo S, Ju J, Sakuragi N. Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene. 32: 3286-95. PMID 22847613 DOI: 10.1038/Onc.2012.334 |
0.778 |
|
| 2013 |
Zhai H, Karaayvaz M, Dong P, Sakuragi N, Ju J. Abstract 5293: Prognostic significance of miR-194 in endometrial cancer. Cancer Research. 73: 5293-5293. DOI: 10.1158/1538-7445.Am2013-5293 |
0.796 |
|
| 2013 |
Karaayvaz M, Zhai H, Ju J. Abstract 4185: miR-129 is a potential tumor suppressor in colorectal cancer by regulating apoptosis and modulating fluropyrimidine based chemosensitivity. Cancer Research. 73: 4185-4185. DOI: 10.1158/1538-7445.Am2013-4185 |
0.801 |
|
| 2013 |
Zhai H, Fesler A, Schee K, Fodstad Ø, Flatmark K, Ju J. Abstract 1840: Clinical significance of lincRNA-p21 in colorectal cancer. Cancer Research. 73: 1840-1840. DOI: 10.1158/1538-7445.Am2013-1840 |
0.389 |
|
| 2012 |
Ju J. Beyond Thymidylate Synthase and Dihydrofolate Reductase: Impact of Non-coding microRNAs in Anticancer Chemoresistance. Current Enzyme Inhibition. 8: 118-123. PMID 24683387 DOI: 10.2174/157340812800793228 |
0.336 |
|
| 2012 |
Xu X, Gnatenko DV, Ju J, Hitchcock IS, Martin DW, Zhu W, Bahou WF. Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms. Blood. 120: 3575-85. PMID 22869791 DOI: 10.1182/Blood-2012-02-411264 |
0.578 |
|
| 2012 |
Shi L, Wu C, Wu J, Zhou W, Ji M, Zhang H, Zhao J, Huang Y, Pei H, Li Z, Ju J, Jiang J. Computed tomography-guided permanent brachytherapy for locoregional recurrent gastric cancer. Radiation Oncology (London, England). 7: 114. PMID 22827960 DOI: 10.1186/1748-717X-7-114 |
0.305 |
|
| 2012 |
Li J, Zucker S, Pulkoski-Gross A, Kuscu C, Karaayvaz M, Ju J, Yao H, Song E, Cao J. Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking. Plos One. 7: e38403. PMID 22679501 DOI: 10.1371/Journal.Pone.0038403 |
0.612 |
|
| 2012 |
Wang M, Li C, Nie H, Lv X, Qu Y, Yu B, Su L, Li J, Chen X, Ju J, Yu Y, Yan M, Gu Q, Zhu Z, Liu B. Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. Febs Letters. 586: 2382-8. PMID 22677169 DOI: 10.1016/j.febslet.2012.05.050 |
0.597 |
|
| 2012 |
Zhai H, Song B, Xu X, Zhu W, Ju J. Inhibition of autophagy and tumor growth in colon cancer by miR-502. Oncogene. 32: 1570-9. PMID 22580605 DOI: 10.1038/Onc.2012.167 |
0.675 |
|
| 2012 |
Karaayvaz M, Zhang C, Liang S, Shroyer KR, Ju J. Prognostic significance of miR-205 in endometrial cancer. Plos One. 7: e35158. PMID 22514717 DOI: 10.1371/Journal.Pone.0035158 |
0.782 |
|
| 2012 |
Li C, Nie H, Wang M, Su L, Li J, Yu B, Wei M, Ju J, Yu Y, Yan M, Gu Q, Zhu Z, Liu B. MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Letters. 320: 189-97. PMID 22388101 DOI: 10.1016/j.canlet.2012.02.030 |
0.571 |
|
| 2012 |
Wang W, Sun J, Li F, Li R, Gu Y, Liu C, Yang P, Zhu M, Chen L, Tian W, Zhou H, Mao Y, Zhang L, Jiang J, Wu C, ... ... Ju J, et al. A frequent somatic mutation in CD274 3'-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding. Human Mutation. 33: 480-4. PMID 22190470 DOI: 10.1002/humu.22014 |
0.425 |
|
| 2012 |
Zhai H, Song B, Xu X, Zhu W, Ju J. Abstract 2285: Inhibition of autophagy and tumor growth in colon cancer by miR-502 Cancer Research. 72: 2285-2285. DOI: 10.1158/1538-7445.Am2012-2285 |
0.688 |
|
| 2011 |
Ju J. Implications of miRNAs in Colorectal Cancer Chemoresistance. International Drug Discovery. 2011. PMID 25750759 |
0.398 |
|
| 2011 |
Zhai H, Ju J. Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Frontiers in Genetics. 2. PMID 22114584 DOI: 10.3389/Fgene.2011.00078 |
0.482 |
|
| 2011 |
Jiang J, Zheng X, Xu X, Zhou Q, Yan H, Zhang X, Lu B, Wu C, Ju J. Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin. Plos One. 6: e23271. PMID 21876743 DOI: 10.1371/Journal.Pone.0023271 |
0.593 |
|
| 2011 |
Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, Sakuragi N. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Molecular Cancer. 10: 99. PMID 21851624 DOI: 10.1186/1476-4598-10-99 |
0.531 |
|
| 2011 |
Karaayvaz M, Pal T, Song B, Zhang C, Georgakopoulos P, Mehmood S, Burke S, Shroyer K, Ju J. Prognostic significance of miR-215 in colon cancer. Clinical Colorectal Cancer. 10: 340-7. PMID 21752725 DOI: 10.1016/J.Clcc.2011.06.002 |
0.794 |
|
| 2011 |
Risberg K, Guldvik IJ, Palchaudhuri R, Xi Y, Ju J, Fodstad O, Hergenrother PJ, Andersson Y. Triphenylmethyl derivatives enhances the anticancer effect of immunotoxins. Journal of Immunotherapy (Hagerstown, Md. : 1997). 34: 438-47. PMID 21577141 DOI: 10.1097/Cji.0B013E31821E00Ae |
0.375 |
|
| 2011 |
Wang B, Howel P, Bruheim S, Ju J, Owen LB, Fodstad O, Xi Y. Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array. Plos One. 6: e17167. PMID 21347261 DOI: 10.1371/Journal.Pone.0017167 |
0.335 |
|
| 2011 |
Karaayvaz M, Pal T, Song B, Zhang C, Georgakopoulos P, Mehmood S, Burke S, Shroyer K, Ju J. Abstract 2263: Prognostic significance of miR-215 in colon cancer Cancer Research. 71: 2263-2263. DOI: 10.1158/1538-7445.Am2011-2263 |
0.78 |
|
| 2011 |
Karaayvaz M, Zhang C, Mehmood S, Georgakopoulos P, Burke S, Shroyer K, Liang S, Ju J. Abstract 158: Expression of miR-205 is significantly associated with prognosis of endometrial cancer Cancer Research. 71: 158-158. DOI: 10.1158/1538-7445.Am2011-158 |
0.806 |
|
| 2010 |
Louie E, Nik S, Chen JS, Schmidt M, Song B, Pacson C, Chen XF, Park S, Ju J, Chen EI. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Research : Bcr. 12: R94. PMID 21067584 DOI: 10.1186/Bcr2773 |
0.351 |
|
| 2010 |
Song B, Ju J. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis Expert Reviews in Molecular Medicine. 12. PMID 20942990 DOI: 10.1017/S1462399410001663 |
0.488 |
|
| 2010 |
Botchkina GI, Zuniga ES, Das M, Wang Y, Wang H, Zhu S, Savitt AG, Rowehl RA, Leyfman Y, Ju J, Shroyer K, Ojima I. New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells. Molecular Cancer. 9: 192. PMID 20630067 DOI: 10.1186/1476-4598-9-192 |
0.394 |
|
| 2010 |
Ju J. miRNAs as biomarkers in colorectal cancer diagnosis and prognosis. Bioanalysis. 2: 901-6. PMID 20543966 DOI: 10.4155/bio.10.45 |
0.374 |
|
| 2010 |
Song B, Wang Y, Titmus MA, Botchkina G, Formentini A, Kornmann M, Ju J. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Molecular Cancer. 9: 96. PMID 20433742 DOI: 10.1186/1476-4598-9-96 |
0.636 |
|
| 2010 |
Kudo K, Xi Y, Wang Y, Song B, Chu E, Ju J, Russo JJ, Ju J. Translational control analysis by translationally active RNA capture/microarray analysis (TrIP-Chip). Nucleic Acids Research. 38: e104. PMID 20123731 DOI: 10.1093/Nar/Gkq024 |
0.305 |
|
| 2010 |
Wang B, Wang XF, Howell P, Qian X, Huang K, Riker AI, Ju J, Xi Y. A personalized microRNA microarray normalization method using a logistic regression model. Bioinformatics (Oxford, England). 26: 228-34. PMID 19933824 DOI: 10.1093/Bioinformatics/Btp655 |
0.425 |
|
| 2010 |
Shevde LA, Metge BJ, Mitra A, Xi Y, Ju J, King JA, Samant RS. Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin. Journal of Cellular and Molecular Medicine. 14: 1693-706. PMID 19538464 DOI: 10.1111/J.1582-4934.2009.00821.X |
0.585 |
|
| 2010 |
Botchkina GI, Ju J, Savitt AG, Rowehl RA, Zuniga E, Das M, Wang H, Zhu S, Ojima I. Abstract 3331: New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in colon and prostate CSCs Cancer Research. 70: 3331-3331. DOI: 10.1158/1538-7445.Am10-3331 |
0.38 |
|
| 2010 |
Song B, Karaayvaz M, Ju J. Abstract 2103: miR-140 and miR-192 are potential tumor suppressors through inhibiting cellular proliferation and restoring cell cycle control in breast cancer cell lines Cancer Research. 70: 2103-2103. DOI: 10.1158/1538-7445.Am10-2103 |
0.798 |
|
| 2010 |
Wang B, Howell P, Wang X, Qian X, Huang K, Riker A, Ju J, Xi Y. Abstract 1984: A novel logistic regression model for microRNA microarray normalization Cancer Research. 70: 1984-1984. DOI: 10.1158/1538-7445.Am10-1984 |
0.461 |
|
| 2009 |
Mishra PJ, Song B, Mishra PJ, Wang Y, Humeniuk R, Banerjee D, Merlino G, Ju J, Bertino JR. MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism. Plos One. 4: e8445. PMID 20041160 DOI: 10.1371/Journal.Pone.0008445 |
0.651 |
|
| 2009 |
Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, Fodstad O, Ju J. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene. 28: 4065-74. PMID 19734943 DOI: 10.1038/Onc.2009.274 |
0.667 |
|
| 2009 |
Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis. Cancer Genomics & Proteomics. 6: 19-29. PMID 19451087 |
0.312 |
|
| 2009 |
Fillmore RA, Mitra A, Xi Y, Ju J, Scammell J, Shevde LA, Samant RS. Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth. International Journal of Cancer. 125: 556-64. PMID 19358268 DOI: 10.1002/Ijc.24276 |
0.313 |
|
| 2008 |
Gavin EJ, Song B, Wang Y, Xi Y, Ju J. Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatin. Plos One. 3: e4054. PMID 19112505 DOI: 10.1371/Journal.Pone.0004054 |
0.457 |
|
| 2008 |
Song B, Wang Y, Kudo K, Gavin EJ, Xi Y, Ju J. miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 8080-6. PMID 19088023 DOI: 10.1158/1078-0432.Ccr-08-1422 |
0.642 |
|
| 2008 |
Ren S, Liu S, Howell P, Xi Y, Enkemann SA, Ju J, Riker AI. The impact of genomics in understanding human melanoma progression and metastasis. Cancer Control : Journal of the Moffitt Cancer Center. 15: 202-15. PMID 18596672 DOI: 10.1177/107327480801500303 |
0.329 |
|
| 2008 |
Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. Bmc Medical Genomics. 1: 13. PMID 18442402 DOI: 10.1186/1755-8794-1-13 |
0.343 |
|
| 2008 |
Rappa G, Mercapide J, Anzanello F, Prasmickaite L, Xi Y, Ju J, Fodstad O, Lorico A. Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Experimental Cell Research. 314: 2110-22. PMID 18423605 DOI: 10.1016/J.Yexcr.2008.03.008 |
0.369 |
|
| 2008 |
Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. Breast Cancer Research : Bcr. 10: R22. PMID 18328103 DOI: 10.1186/Bcr1874 |
0.346 |
|
| 2008 |
Xi Y, Formentini A, Nakajima G, Kornmann M, Ju J. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer. Oncology Reports. 19: 257-62. PMID 18097604 DOI: 10.3892/Or.19.1.257 |
0.407 |
|
| 2007 |
Xi Y, Edwards JR, Ju J. Investigation of miRNA biology by bioinformatic tools and impact of miRNAs in colorectal cancer--regulatory relationship of c-Myc and p53 with miRNAs. Cancer Informatics. 3: 245-53. PMID 18079974 |
0.36 |
|
| 2007 |
Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, Ju J. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. Rna (New York, N.Y.). 13: 1668-74. PMID 17698639 DOI: 10.1261/Rna.642907 |
0.449 |
|
| 2007 |
Ju J, Schmitz JC, Song B, Kudo K, Chu E. Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 4245-51. PMID 17634554 DOI: 10.1158/1078-0432.Ccr-06-2890 |
0.437 |
|
| 2006 |
Nakajima G, Hayashi K, Xi Y, Kudo K, Uchida K, Takasaki K, Yamamoto M, Ju J. Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. Cancer Genomics & Proteomics. 3: 317-324. PMID 18172508 |
0.606 |
|
| 2006 |
Xi Y, Formentini A, Chien M, Weir DB, Russo JJ, Ju J, Kornmann M, Ju J. Prognostic Values of microRNAs in Colorectal Cancer. Biomarker Insights. 2: 113-121. PMID 18079988 DOI: 10.4137/Bmi.S0 |
0.668 |
|
| 2006 |
Xi Y, Nakajima G, Hamil T, Fodstad O, Riker A, Ju J. Association of insulin-like growth factor binding protein-3 expression with melanoma progression. Molecular Cancer Therapeutics. 5: 3078-84. PMID 17172410 DOI: 10.1158/1535-7163.Mct-06-0424 |
0.344 |
|
| 2006 |
Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 2014-24. PMID 16609010 DOI: 10.1158/1078-0432.Ccr-05-1853 |
0.406 |
|
| 2006 |
Xi Y, Nakajima G, Schmitz JC, Chu E, Ju J. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer. Bmc Genomics. 7: 68. PMID 16584549 DOI: 10.1186/1471-2164-7-68 |
0.423 |
|
| 1999 |
Ju J, Pedersen-Lane J, Maley F, Chu E. Regulation of p53 expression by thymidylate synthase Proceedings of the National Academy of Sciences of the United States of America. 96: 3769-3774. PMID 10097112 DOI: 10.1073/Pnas.96.7.3769 |
0.377 |
|
| 1999 |
Chu E, Copur SM, Ju J, Chen TM, Khleif S, Voeller DM, Mizunuma N, Patel M, Maley GF, Maley F, Allegra CJ. Thymidylate Synthase Protein and p53 mRNA Form an In Vivo Ribonucleoprotein Complex Molecular and Cellular Biology. 19: 1582-1594. PMID 9891091 DOI: 10.1128/Mcb.19.2.1582 |
0.372 |
|
| Show low-probability matches. |